Galectin Therapeutics GALT reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Galectin Therapeutics missed estimated earnings by 21.43%, reporting an EPS of $-0.17 versus an estimate of $-0.14.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 1.86% drop in the share price the next day.
To track all earnings releases for Galectin Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.